KMT5A and chronic myelogenous leukemia, BCR-ABL1 positive: For example, in hepatocellular carcinoma (HCC), non-small cell lung carcinoma (NSCLC), bladder cancer, chronic myelogenous leukemia, and NHL13,16,17, SET8 functions largely as an oncogene.